Article info

Download PDFPDF
Responsiveness to anti-tumour necrosis factor α therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients
  1. C T M van der Pouw Kraan, VU University Medical Centre, Department of Molecular and Cellular Biology & Immunology, C262, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; t.vanderpouwkraan{at}vumc.nl
View Full Text

Citation

van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, et al
Responsiveness to anti-tumour necrosis factor α therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients

Publication history

  • Accepted November 18, 2007
  • First published November 27, 2007.
Online issue publication 
November 02, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.